Literature DB >> 32805346

Insulin-like growth factor 1-receptor signaling stimulates GRP78 expression through the PI3K/AKT/mTOR/ATF4 axis.

Dat P Ha1, Amy S Lee2.   

Abstract

GRP78, a major molecular chaperone, is critical for the folding and maturation of membrane and secretory proteins and serves as the master regulator of the unfolded protein response. Thus, GRP78 is frequently upregulated in highly proliferative cells to cope with elevated protein synthesis and metabolic stress. IGF-1 is a potent regulator of cell growth, metabolism and survival. Previously we discovered that GRP78 is a novel downstream target of IGF-1 signaling by utilizing mouse embryonic fibroblast model systems where the IGF-1 receptor (IGF-1R) was either overexpressed (R+) or knockout (R-). Here we investigated the mechanisms whereby GRP78 is upregulated in the R+ cells. Our studies revealed that suppression of PI3K/AKT/mTOR downstream of IGF-1R signaling resulted in concurrent decrease in GRP78 and the transcription factor ATF4. Through knock-down and overexpression studies, we established ATF4 as the essential downstream nodal of the PI3K/AKT/mTOR signaling pathway critical for GRP78 transcriptional upregulation mediated by IGF-1R.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATF4; GRP78; Growth factor signaling; IGF-1; PI3K/AKT/mTOR

Year:  2020        PMID: 32805346      PMCID: PMC7530066          DOI: 10.1016/j.cellsig.2020.109736

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  41 in total

Review 1.  Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential.

Authors:  Amy S Lee
Journal:  Nat Rev Cancer       Date:  2014-04       Impact factor: 60.716

2.  Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-β signaling.

Authors:  Yuan-Li Tsai; Dat P Ha; He Zhao; Anthony J Carlos; Shan Wei; Tsam Kiu Pun; Kaijin Wu; Ebrahim Zandi; Kevin Kelly; Amy S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-13       Impact factor: 11.205

3.  Adapting to cell stress from inside and out.

Authors:  Kirk A Staschke; Ronald C Wek
Journal:  Nat Cell Biol       Date:  2019-07       Impact factor: 28.824

Review 4.  IGF1 receptor signaling pathways.

Authors:  Fumihiko Hakuno; Shin-Ichiro Takahashi
Journal:  J Mol Endocrinol       Date:  2018-03-13       Impact factor: 5.098

Review 5.  The Impact of the ER Unfolded Protein Response on Cancer Initiation and Progression: Therapeutic Implications.

Authors:  Cynthia Lebeaupin; Jing Yong; Randal J Kaufman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Control of cell size through phosphorylation of upstream binding factor 1 by nuclear phosphatidylinositol 3-kinase.

Authors:  Robert Drakas; Xiao Tu; Renato Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-14       Impact factor: 11.205

Review 7.  Targeting the ATF4 pathway in cancer therapy.

Authors:  Dean C Singleton; Adrian L Harris
Journal:  Expert Opin Ther Targets       Date:  2012-09-26       Impact factor: 6.902

Review 8.  Activating transcription factor 4.

Authors:  Kurosh Ameri; Adrian L Harris
Journal:  Int J Biochem Cell Biol       Date:  2007-01-28       Impact factor: 5.085

9.  Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor.

Authors:  C Sell; M Rubini; R Rubin; J P Liu; A Efstratiadis; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  mTORC1 amplifies the ATF4-dependent de novo serine-glycine pathway to supply glycine during TGF-β1-induced collagen biosynthesis.

Authors:  Brintha Selvarajah; Ilan Azuelos; Manuela Platé; Delphine Guillotin; Ellen J Forty; Greg Contento; Hannah V Woodcock; Matthew Redding; Adam Taylor; Gino Brunori; Pascal F Durrenberger; Riccardo Ronzoni; Andy D Blanchard; Paul F Mercer; Dimitrios Anastasiou; Rachel C Chambers
Journal:  Sci Signal       Date:  2019-05-21       Impact factor: 8.192

View more
  1 in total

1.  OSU-03012 Disrupts Akt Signaling and Prevents Endometrial Carcinoma Progression in vitro and in vivo.

Authors:  Leilei Ding; Chenchen Ren; Li Yang; Zimeng Wu; Feiyan Li; Dongyuan Jiang; Yuanhang Zhu; Jie Lu
Journal:  Drug Des Devel Ther       Date:  2021-04-30       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.